TY - JOUR
T1 - The Shamrock lumbar plexus block
T2 - A dose-finding study
AU - Sauter, Axel R.
AU - Ullensvang, Kyrre
AU - Niemi, Geir
AU - Lorentzen, Havard T.
AU - Bendtsen, Thomas Fichtner
AU - Børglum, Jens
AU - Pripp, Are Hugo
AU - Romundstad, Luis
PY - 2015/11
Y1 - 2015/11
N2 - BACKGROUND The Shamrock technique is a new method for ultrasound-guided lumbar plexus blockade. Data on the optimal local anaesthetic dose are not available. OBJECTIVE The objective of this study is to estimate the effective dose of ropivacaine 0.5% for a Shamrock lumbar plexus block. DESIGN A prospective dose-finding study using Dixon's upand- down sequential method. SETTING University Hospital Orthopaedic Anaesthesia Unit. INTERVENTION Shamrock lumbar plexus block performance and block assessment were scheduled preoperatively. Ropivacaine 0.5% was titrated with the Dixon and Massey up-and-down method using a stepwise change of 5ml in each consecutive patient. Combined blocks of the femoral, the lateral femoral cutaneous and the obturator nerve were prerequisite for a successful lumbar plexus block. PATIENTS Thirty patients scheduled for lower limb orthopaedic surgery completed the study. MAIN OUTCOME MEASURES The minimum effective anaesthetic volume of ropivacaine 0.5% (ED50) to achieve a successful Shamrock lumbar plexus block in 50% of the patients. Further analysis of the data was performed with a logistic regression model to calculate ED95 and to estimate the effective doses for a sensory lumbar plexus block not requiring a motor block of the femoral nerve. RESULTS The Dixon and Massay estimate of the ED50 was 20.4 [95% confidence interval (95% CI) 13.9 to 30.0] ml ropivacaine 0.5%. The logistic regression estimate of theED95 was 36.0 (95% CI 19.7 to 52.2) ml ropivacaine 0.5%. For a sensory lumbar plexus block, the ED50 was 17.1 (95%CI 12.3 to 21.9) ml and the ED95 was 25.8 (95% CI 18.6 to 33.1) ml. CONCLUSION A volume of 20.4 ml ropivacaine 0.5% provided a successful Shamrock lumbar plexus block in 50% of the patients. A volume of 36.0 ml would be successful in 95% of the patients. TRIAL REGISTRATION ClinicalTrials.gov identifier NCT01956617.
AB - BACKGROUND The Shamrock technique is a new method for ultrasound-guided lumbar plexus blockade. Data on the optimal local anaesthetic dose are not available. OBJECTIVE The objective of this study is to estimate the effective dose of ropivacaine 0.5% for a Shamrock lumbar plexus block. DESIGN A prospective dose-finding study using Dixon's upand- down sequential method. SETTING University Hospital Orthopaedic Anaesthesia Unit. INTERVENTION Shamrock lumbar plexus block performance and block assessment were scheduled preoperatively. Ropivacaine 0.5% was titrated with the Dixon and Massey up-and-down method using a stepwise change of 5ml in each consecutive patient. Combined blocks of the femoral, the lateral femoral cutaneous and the obturator nerve were prerequisite for a successful lumbar plexus block. PATIENTS Thirty patients scheduled for lower limb orthopaedic surgery completed the study. MAIN OUTCOME MEASURES The minimum effective anaesthetic volume of ropivacaine 0.5% (ED50) to achieve a successful Shamrock lumbar plexus block in 50% of the patients. Further analysis of the data was performed with a logistic regression model to calculate ED95 and to estimate the effective doses for a sensory lumbar plexus block not requiring a motor block of the femoral nerve. RESULTS The Dixon and Massay estimate of the ED50 was 20.4 [95% confidence interval (95% CI) 13.9 to 30.0] ml ropivacaine 0.5%. The logistic regression estimate of theED95 was 36.0 (95% CI 19.7 to 52.2) ml ropivacaine 0.5%. For a sensory lumbar plexus block, the ED50 was 17.1 (95%CI 12.3 to 21.9) ml and the ED95 was 25.8 (95% CI 18.6 to 33.1) ml. CONCLUSION A volume of 20.4 ml ropivacaine 0.5% provided a successful Shamrock lumbar plexus block in 50% of the patients. A volume of 36.0 ml would be successful in 95% of the patients. TRIAL REGISTRATION ClinicalTrials.gov identifier NCT01956617.
UR - http://www.scopus.com/inward/record.url?scp=84979096816&partnerID=8YFLogxK
U2 - 10.1097/EJA.0000000000000265
DO - 10.1097/EJA.0000000000000265
M3 - Article
C2 - 26426575
AN - SCOPUS:84979096816
SN - 0265-0215
VL - 32
SP - 764
EP - 770
JO - European Journal of Anaesthesiology
JF - European Journal of Anaesthesiology
IS - 11
ER -